Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans
Abstract
:1. Introduction
2. Materials and Methods
2.1. C. albicans Strains, Media and Growth Conditions
2.2. Peptides and Reagents
2.3. Cell Susceptibility to LfcinB15
2.4. Minimal Inhibitory Concentration (MIC) of LfcinB15
2.5. Assessment of Biofilm Formation
2.6. Fluorescence Microscopy
2.7. Liposome Preparation and Determination of Membrane Disturbance by Measuring Calcein Leakage
2.8. Measurement of Intracellular ROS
2.9. Cell Rescue Assay Using ROS Scavengers
2.10. Protein Extraction and Western Blotting
2.11. Measurement of the Mitochondrial Membrane Potential
2.12. Measurement of Intracellular and Extracellular ATP Levels
2.13. Oxygen Consumption Rate (OCR) Measurement Using High-Resolution Respirometry
2.14. Determination of the Association between LfcinB15 and Mitochondrial Respiration
2.15. Statistical Analysis
3. Results
3.1. LfcinB15 Exerts Anti-Candida Activity against Both Planktonic and Biofilm Cells
3.2. LfcinB15 Also Exerts Antifungal Activity against Clinical Isolates of Candida Species
3.3. LfcinB15 Disturbs Membrane Integrity and Enters C. albicans Cells
3.4. LfcinB15-Induced ROS Production Is Related to Its Candidacidal Activity
3.5. The Hog1 and Mkc1 Mitogen-Activated Protein Kinases (MAPKs) Are Activated in Response to LfcinB15
3.6. LfcinB15 Also Causes Mitochondrial Dysfunction
3.7. The Effect of LfcinB15 on Mitochondria Is Associated with the Candidacidal Activity of the Peptide
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Sardi, J.C.; Scorzoni, L.; Bernardi, T.; Fusco-Almeida, A.M.; Mendes Giannini, M.J. Candida species: Current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J. Med. Microbiol. 2013, 62, 10–24. [Google Scholar] [CrossRef] [PubMed]
- Ben-Ami, R. Treatment of Invasive Candidiasis: A Narrative Review. J. Fungi 2018, 4, 97. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Brissaud, O.; Guichoux, J.; Harambat, J.; Tandonnet, O.; Zaoutis, T. Invasive fungal disease in PICU: Epidemiology and risk factors. Ann. Intensive Care 2012, 2, 6. [Google Scholar] [CrossRef] [PubMed]
- Arastehfar, A.; Lass-Florl, C.; Garcia-Rubio, R.; Daneshnia, F.; Ilkit, M.; Boekhout, T.; Gabaldon, T.; Perlin, D.S. The quiet and underappreciated rise of drug-resistant invasive fungal pathogens. J. Fungi 2020, 6, 138. [Google Scholar] [CrossRef] [PubMed]
- Bondaryk, M.; Staniszewska, M.; Zielinska, P.; Urbanczyk-Lipkowska, Z. Natural antimicrobial peptides as inspiration for design of a new generation antifungal compounds. J. Fungi 2017, 3, 46. [Google Scholar] [CrossRef]
- Mahlapuu, M.; Hakansson, J.; Ringstad, L.; Bjorn, C. Antimicrobial peptides: An emerging category of therapeutic agents. Front. Cell. Infect. Microbiol. 2016, 6, 194. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Steckbeck, J.D.; Deslouches, B.; Montelaro, R.C. Antimicrobial peptides: New drugs for bad bugs? Expert Opin. Biol. Ther. 2014, 14, 11–14. [Google Scholar] [CrossRef] [Green Version]
- Midura-Nowaczek, K.; Markowska, A. Antimicrobial peptides and their analogs: Searching for new potential therapeutics. Perspect. Med. Chem. 2014, 6, S13215. [Google Scholar] [CrossRef] [Green Version]
- Hollmann, A.; Martinez, M.; Maturana, P.; Semorile, L.C.; Maffia, P.C. Antimicrobial peptides: Interaction with model and biological membranes and synergism with chemical antibiotics. Front. Chem. 2018, 6, 204. [Google Scholar] [CrossRef] [Green Version]
- Le, C.F.; Fang, C.M.; Sekaran, S.D. Intracellular targeting mechanisms by antimicrobial peptides. Antimicrob. Agents Chemother. 2017, 61, e02340-16. [Google Scholar] [CrossRef] [Green Version]
- Puri, S.; Edgerton, M. How does it kill?: Understanding the candidacidal mechanism of salivary histatin 5. Eukaryot. Cell 2014, 13, 958–964. [Google Scholar] [CrossRef] [Green Version]
- Mardirossian, M.; Perebaskine, N.; Benincasa, M.; Gambato, S.; Hofmann, S.; Huter, P.; Muller, C.; Hilpert, K.; Innis, C.A.; Tossi, A.; et al. The dolphin proline-rich antimicrobial peptide Tur1A inhibits protein synthesis by targeting the bacterial ribosome. Cell Chem. Biol. 2018, 25, 530–539.e7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Adlerova, L.; Bartoskova, A.; Faldyna, M. Lactoferrin: A review. Vet. Med. 2008, 53, 457–468. [Google Scholar] [CrossRef] [Green Version]
- Rosa, L.; Cutone, A.; Lepanto, M.S.; Paesano, R.; Valenti, P. Lactoferrin: A natural glycoprotein involved in iron and inflammatory homeostasis. Int. J. Mol. Sci. 2017, 18, 1985. [Google Scholar] [CrossRef]
- Jenssen, H.; Hancock, R.E. Antimicrobial properties of lactoferrin. Biochimie 2009, 91, 19–29. [Google Scholar] [CrossRef]
- Gifford, J.L.; Hunter, H.N.; Vogel, H.J. Lactoferricin: A lactoferrin-derived peptide with antimicrobial, antiviral, antitumor and immunological properties. Cell. Mol. Life Sci. 2005, 62, 2588–2598. [Google Scholar] [CrossRef] [PubMed]
- Bellamy, W.; Takase, M.; Yamauchi, K.; Wakabayashi, H.; Kawase, K.; Tomita, M. Identification of the bactericidal domain of lactoferrin. Biochim. Biophys. Acta BBA Protein Struct. Mol. Enzymol. 1992, 1121, 130–136. [Google Scholar] [CrossRef]
- Vorland, L.H.; Ulvatne, H.; Andersen, J.; Haukland, H.; Rekdal, O.; Svendsen, J.S.; Gutteberg, T.J. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand. J. Infect. Dis. 1998, 30, 513–517. [Google Scholar]
- Bruni, N.; Capucchio, M.T.; Biasibetti, E.; Pessione, E.; Cirrincione, S.; Giraudo, L.; Corona, A.; Dosio, F. Antimicrobial activity of lactoferrin-related peptides and applications in human and veterinary medicine. Molecules 2016, 21, 752. [Google Scholar] [CrossRef]
- Hao, Y.; Yang, N.; Teng, D.; Wang, X.; Mao, R.; Wang, J. A review of the design and modification of lactoferricins and their derivatives. Biometals 2018, 31, 331–341. [Google Scholar] [CrossRef]
- Fernandes, K.E.; Carter, D.A. The antifungal activity of lactoferrin and its derived peptides: Mechanisms of action and synergy with drugs against fungal pathogens. Front. Microbiol. 2017, 8, 2. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Liu, Y.; Han, F.; Xie, Y.; Wang, Y. Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Biometals 2011, 24, 1069–1078. [Google Scholar] [CrossRef] [PubMed]
- Noble, S.M.; French, S.; Kohn, L.A.; Chen, V.; Johnson, A.D. Systematic screens of a Candida albicans homozygous deletion library decouple morphogenetic switching and pathogenicity. Nat. Genet. 2010, 42, 590–598. [Google Scholar] [CrossRef] [Green Version]
- Yu, H.Y.; Tu, C.H.; Yip, B.S.; Chen, H.L.; Cheng, H.T.; Huang, K.C.; Lo, H.J.; Cheng, J.W. Easy strategy to increase salt resistance of antimicrobial peptides. Antimicrob. Agents Chemother. 2011, 55, 4918–4921. [Google Scholar] [CrossRef] [Green Version]
- Wayne, P.A. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts, 3rd ed.; Approved Standard, CLSI Document M27-A3; Clinical and Laboratory Standards Institute: Annapolis Junction, MD, USA, 2008. [Google Scholar]
- Rothstein, D.M.; Spacciapoli, P.; Tran, L.T.; Xu, T.; Roberts, F.D.; Dalla Serra, M.; Buxton, D.K.; Oppenheim, F.G.; Friden, P. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Antimicrob. Agents Chemother. 2001, 45, 1367–1373. [Google Scholar] [CrossRef] [Green Version]
- Chen, H.F.; Lan, C.Y. Role of SFP1 in the regulation of Candida albicans biofilm formation. PLoS ONE 2015, 10, e0129903. [Google Scholar] [CrossRef] [PubMed]
- Huang, W.N.; Sue, S.C.; Wang, D.S.; Wu, P.L.; Wu, W.G. Peripheral binding mode and penetration depth of cobra cardiotoxin on phospholipid membranes as studied by a combined FTIR and computer simulation approach. Biochemistry 2003, 42, 7457–7466. [Google Scholar] [CrossRef]
- Xue, Y.P.; Kao, M.C.; Lan, C.Y. Novel mitochondrial complex I-inhibiting peptides restrain NADH dehydrogenase activity. Sci. Rep. 2019, 9, 13694. [Google Scholar] [CrossRef]
- Chen, Y.W.; Yeh, Y.C.; Chen, H.F.; Chen, R.C.; Lin, G.Y.; Chen, Y.T.; Lan, C.Y. The small GTPase Rhb1 is involved in the cell response to fluconazole in Candida albicans. FEMS Yeast Res. 2019, 19, foz005. [Google Scholar] [CrossRef] [Green Version]
- Lis, M.; Bobek, L.A. Proteomic and metabolic characterization of a Candida albicans mutant resistant to the antimicrobial peptide MUC7 12-mer. FEMS Immunol. Med. Microbiol. 2008, 54, 80–91. [Google Scholar] [CrossRef] [Green Version]
- Wall, G.; Montelongo-Jauregui, D.; Vidal Bonifacio, B.; Lopez-Ribot, J.L.; Uppuluri, P. Candida albicans biofilm growth and dispersal: Contributions to pathogenesis. Curr. Opin. Microbiol. 2019, 52, 1–6. [Google Scholar] [CrossRef]
- Lin, G.Y.; Chen, H.F.; Xue, Y.P.; Yeh, Y.C.; Chen, C.L.; Liu, M.S.; Cheng, W.C.; Lan, C.Y. The antimicrobial peptides P-113Du and P-113Tri function against Candida albicans. Antimicrob. Agents Chemother. 2016, 60, 6369–6373. [Google Scholar] [CrossRef] [Green Version]
- Wakabayashi, H.; Hiratani, T.; Uchida, K.; Yamaguchi, H. Antifungal spectrum and fungicidal mechanism of an N-terminal peptide of bovine lactoferrin. J. Infect. Chemother. 1996, 1, 185–189. [Google Scholar] [CrossRef]
- Roscetto, E.; Contursi, P.; Vollaro, A.; Fusco, S.; Notomista, E.; Catania, M.R. Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates. Sci. Rep. 2018, 8, 17570. [Google Scholar] [CrossRef]
- Kumar, P.; Kizhakkedathu, J.N.; Straus, S.K. Antimicrobial peptides: Diversity, mechanism of action and strategies to improve the activity and biocompatibility in vivo. Biomolecules 2018, 8, 4. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Kim, S.; Lee, D.G. Role of calcium in reactive oxygen species-induced apoptosis in Candida albicans: An antifungal mechanism of antimicrobial peptide, PMAP-23. Free Radic. Res. 2019, 53, 8–17. [Google Scholar] [CrossRef]
- Seyedjavadi, S.S.; Khani, S.; Eslamifar, A.; Ajdary, S.; Goudarzi, M.; Halabian, R.; Akbari, R.; Zare-Zardini, H.; Imani Fooladi, A.A.; Amani, J.; et al. The antifungal peptide MCh-AMP1 derived from Matricaria chamomilla inhibits Candida albicans growth via inducing ROS generation and altering fungal cell membrane permeability. Front. Microbiol. 2019, 10, 3150. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Wang, K.; Dang, W.; Xie, J.; Zhu, R.; Sun, M.; Jia, F.; Zhao, Y.; An, X.; Qiu, S.; Li, X.; et al. Antimicrobial peptide protonectin disturbs the membrane integrity and induces ROS production in yeast cells. Biochim. Biophys. Acta 2015, 1848, 2365–2373. [Google Scholar] [CrossRef] [Green Version]
- De Nollin, S.; Borgers, M. Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole. Antimicrob. Agents Chemother. 1975, 7, 704–711. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Vandenbosch, D.; Braeckmans, K.; Nelis, H.J.; Coenye, T. Fungicidal activity of miconazole against Candida spp. biofilms. J. Antimicrob. Chemother. 2010, 65, 694–700. [Google Scholar] [CrossRef] [Green Version]
- Perrone, G.G.; Tan, S.X.; Dawes, I.W. Reactive oxygen species and yeast apoptosis. Biochim. Biophys. Acta 2008, 1783, 1354–1368. [Google Scholar] [CrossRef] [Green Version]
- Farrugia, G.; Balzan, R. Oxidative stress and programmed cell death in yeast. Front. Oncol. 2012, 2, 64. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Lee, W.; Lee, D.G. Reactive oxygen species modulate itraconazole-induced apoptosis via mitochondrial disruption in Candida albicans. Free Radic. Res. 2018, 52, 39–50. [Google Scholar] [CrossRef] [PubMed]
- Sun, S.Y. N-acetylcysteine, reactive oxygen species and beyond. Cancer Biol. Ther. 2010, 9, 109–110. [Google Scholar] [CrossRef] [Green Version]
- Day, A.M.; Quinn, J. Stress-activated protein kinases in human fungal pathogens. Front. Cell Infect. Microbiol. 2019, 9, 261. [Google Scholar] [CrossRef] [Green Version]
- Argimon, S.; Fanning, S.; Blankenship, J.R.; Mitchell, A.P. Interaction between the Candida albicans high-osmolarity glycerol (HOG) pathway and the response to human beta-defensins 2 and 3. Eukaryot. Cell 2011, 10, 272–275. [Google Scholar] [CrossRef] [Green Version]
- Vylkova, S.; Jang, W.S.; Li, W.; Nayyar, N.; Edgerton, M. Histatin 5 initiates osmotic stress response in Candida albicans via activation of the Hog1 mitogen-activated protein kinase pathway. Eukaryot. Cell 2007, 6, 1876–1888. [Google Scholar] [CrossRef] [Green Version]
- Negredo, A.; Monteoliva, L.; Gil, C.; Pla, J.; Nombela, C. Cloning, analysis and one-step disruption of the ARG5, 6 gene of Candida albicans. Microbiology 1997, 143, 297–302. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alonso-Monge, R.; Navarro-Garcia, F.; Molero, G.; Diez-Orejas, R.; Gustin, M.; Pla, J.; Sanchez, M.; Nombela, C. Role of the mitogen-activated protein kinase Hog1p in morphogenesis and virulence of Candida albicans. J. Bacteriol. 1999, 181, 3058–3068. [Google Scholar] [CrossRef] [Green Version]
- Zhao, R.Z.; Jiang, S.; Zhang, L.; Yu, Z.B. Mitochondrial electron transport chain, ROS generation and uncoupling. Int. J. Mol. Med. 2019, 44, 3–15. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Zorova, L.D.; Popkov, V.A.; Plotnikov, E.Y.; Silachev, D.N.; Pevzner, I.B.; Jankauskas, S.S.; Babenko, V.A.; Zorov, S.D.; Balakireva, A.V.; Juhaszova, M.; et al. Mitochondrial membrane potential. Anal. Biochem. 2018, 552, 50–59. [Google Scholar] [CrossRef]
- Duvenage, L.; Munro, C.; Gourlay, C. High resolution respirometry in Candida albicans. Bio Protocol 2019, 9, e3361. [Google Scholar] [CrossRef] [Green Version]
- Brand, M.D.; Nicholls, D.G. Assessing mitochondrial dysfunction in cells. Biochem. J. 2011, 435, 297–312. [Google Scholar] [CrossRef] [Green Version]
- Skrzypek, M.S.; Binkley, J.; Binkley, G.; Miyasato, S.R.; Simison, M.; Sherlock, G. The Candida genome database (CGD): Incorporation of Assembly 22, systematic identifiers and visualization of high throughput sequencing data. Nucleic Acids Res. 2017, 45, D592–D596. [Google Scholar] [CrossRef] [Green Version]
- Chen, R.C.; Lan, C.Y. Human antimicrobial peptide hepcidin 25-induced apoptosis in Candida albicans. Microorganisms 2020, 8, 585. [Google Scholar] [CrossRef] [Green Version]
- Helmerhorst, E.J.; Troxler, R.F.; Oppenheim, F.G. The human salivary peptide histatin 5 exerts its antifungal activity through the formation of reactive oxygen species. Proc. Natl. Acad. Sci. USA 2001, 98, 14637–14642. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Murphy, M.P. Mitochondrial dysfunction indirectly elevates ROS production by the endoplasmic reticulum. Cell Metab. 2013, 18, 145–146. [Google Scholar] [CrossRef] [Green Version]
- Li, Y.; Shan, M.; Zhu, Y.; Yao, H.; Li, H.; Gu, B.; Zhu, Z. Kalopanaxsaponin A induces reactive oxygen species mediated mitochondrial dysfunction and cell membrane destruction in Candida albicans. PLoS ONE 2020, 15, e0243066. [Google Scholar] [CrossRef]
- Helmerhorst, E.J.; Breeuwer, P.; van’t Hof, W.; Walgreen-Weterings, E.; Oomen, L.C.; Veerman, E.C.; Amerongen, A.V.; Abee, T. The cellular target of histatin 5 on Candida albicans is the energized mitochondrion. J. Biol. Chem. 1999, 274, 7286–7291. [Google Scholar] [CrossRef] [Green Version]
- Vylkova, S.; Sun, J.N.; Edgerton, M. The role of released ATP in killing Candida albicans and other extracellular microbial pathogens by cationic peptides. Purinergic Signal. 2007, 3, 91–97. [Google Scholar] [CrossRef] [Green Version]
- Koshlukova, S.E.; Araujo, M.W.; Baev, D.; Edgerton, M. Released ATP is an extracellular cytotoxic mediator in salivary histatin 5-induced killing of Candida albicans. Infect. Immun. 2000, 68, 6848–6856. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Ledderose, C.; Junger, W.G. Mitochondria synergize with P2 receptors to regulate human T cell function. Front. Immunol. 2020, 11, 549889. [Google Scholar] [CrossRef]
- Koshlukova, S.E.; Lloyd, T.L.; Araujo, M.W.; Edgerton, M. Salivary histatin 5 induces non-lytic release of ATP from Candida albicans leading to cell death. J. Biol. Chem. 1999, 274, 18872–18879. [Google Scholar] [CrossRef] [Green Version]
- Kojima, K.; Takano, Y.; Yoshimi, A.; Tanaka, C.; Kikuchi, T.; Okuno, T. Fungicide activity through activation of a fungal signalling pathway. Mol. Microbiol. 2004, 53, 1785–1796. [Google Scholar] [CrossRef] [PubMed]
- Buschart, A.; Gremmer, K.; El-Mowafy, M.; van den Heuvel, J.; Mueller, P.P.; Bilitewski, U. A novel functional assay for fungal histidine kinases group III reveals the role of HAMP domains for fungicide sensitivity. J. Biotechnol. 2012, 157, 268–277. [Google Scholar] [CrossRef]
- Cui, S.; Hassan, R.Y.; Heintz-Buschart, A.; Bilitewski, U. Regulation of Candida albicans interaction with macrophages through the activation of HOG pathway by genistein. Molecules 2016, 21, 162. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- El-Mowafy, M.; Bahgat, M.M.; Bilitewski, U. Deletion of the HAMP domains from the histidine kinase CaNik1p of Candida albicans or treatment with fungicides activates the MAP kinase Hog1p in S. cerevisiae transformants. BMC Microbiol. 2013, 13, 209. [Google Scholar] [CrossRef] [Green Version]
- Elbaz-Alon, Y.; Rosenfeld-Gur, E.; Shinder, V.; Futerman, A.H.; Geiger, T.; Schuldiner, M. A dynamic interface between vacuoles and mitochondria in yeast. Dev. Cell 2014, 30, 95–102. [Google Scholar] [CrossRef] [Green Version]
- Honscher, C.; Mari, M.; Auffarth, K.; Bohnert, M.; Griffith, J.; Geerts, W.; van der Laan, M.; Cabrera, M.; Reggiori, F.; Ungermann, C. Cellular metabolism regulates contact sites between vacuoles and mitochondria. Dev. Cell 2014, 30, 86–94. [Google Scholar] [CrossRef] [Green Version]
- Soto-Heredero, G.; Baixauli, F.; Mittelbrunn, M. Interorganelle communication between mitochondria and the endolysosomal system. Front. Cell Dev. Biol. 2017, 5, 95. [Google Scholar] [CrossRef] [Green Version]
- Mao, X.; Yang, L.; Liu, Y.; Ma, C.; Ma, T.; Yu, Q.; Li, M. Vacuole and mitochondria patch (vCLAMP) protein Vam6 is involved in maintenance of mitochondrial and vacuolar functions under oxidative stress in Candida albicans. Antioxidants 2021, 10, 136. [Google Scholar] [CrossRef]
- Mao, X.; Yang, L.; Fan, Y.; Wang, J.; Cui, D.; Yu, D.; Yu, Q.; Li, M. The vacuole and mitochondria patch (vCLAMP) protein Mcp1 is involved in maintenance of mitochondrial function and mitophagy in Candida albicans. Front. Microbiol. 2021, 12, 633380. [Google Scholar] [CrossRef]
- Duvenage, L.; Munro, C.A.; Gourlay, C.W. The potential of respiration inhibition as a new approach to combat human fungal pathogens. Curr. Genet. 2019, 65, 1347–1353. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Duvenage, L.; Pentland, D.R.; Munro, C.A.; Gourlay, C.W. An analysis of respiratory function and mitochondrial morphology in Candida albicans. bioRxiv 2019, 697516. [Google Scholar] [CrossRef]
- Li, D.; Calderone, R. Exploiting mitochondria as targets for the development of new antifungals. Virulence 2017, 8, 159–168. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Sun, N.; Parrish, R.S.; Calderone, R.A.; Fonzi, W.A. Unique, diverged, and conserved mitochondrial functions influencing Candida albicans respiration. mBio 2019, 10, e00300-19. [Google Scholar] [CrossRef] [Green Version]
Candida spp. | Source a | Strains | MIC (μg/mL) |
---|---|---|---|
C. albicans | ATCC MYA-2876 | SC5314 | 6.25 |
C. albicans | ATCC90028 | YLO12 | 6.25 |
C. albicans | HIV patient | YH050001 | 6.25 |
C. albicans | HIV patient | YH050005 | 12.5 |
C. albicans | HIV patient | YH050072 b | 6.25 |
C. glabrata | ATCC9003 | YLO8 | >50 |
C. glabrata | HIV patient | YH050105 | 50 |
C. krusei | ATCC6258 | YLO6 | 12.5 |
C. krusei | HIV patient | YH050075 b | 6.25 |
C. tropicalis | ATCC13803 | YLO86 b | 3.125 |
C. tropicalis | HIV patient | YH050007 b | 3.125 |
C. tropicalis | HIV patient | YH050013 b | 6.25 |
C. tropicalis | HIV patient | YH050114 b | 6.25 |
C. parapsilosis | ATCC22019 | YLO7 | 3.125 |
C. dubliniensis | HIV patient | YH050092 | 12.5 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Chang, C.-K.; Kao, M.-C.; Lan, C.-Y. Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans. J. Fungi 2021, 7, 519. https://0-doi-org.brum.beds.ac.uk/10.3390/jof7070519
Chang C-K, Kao M-C, Lan C-Y. Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans. Journal of Fungi. 2021; 7(7):519. https://0-doi-org.brum.beds.ac.uk/10.3390/jof7070519
Chicago/Turabian StyleChang, Che-Kang, Mou-Chieh Kao, and Chung-Yu Lan. 2021. "Antimicrobial Activity of the Peptide LfcinB15 against Candida albicans" Journal of Fungi 7, no. 7: 519. https://0-doi-org.brum.beds.ac.uk/10.3390/jof7070519